Catalyst Pharmaceutical
CPRX
CPRX
257 hedge funds and large institutions have $1.52B invested in Catalyst Pharmaceutical in 2022 Q4 according to their latest regulatory filings, with 52 funds opening new positions, 97 increasing their positions, 79 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
12% more funds holding
Funds holding: 229 → 257 (+28)
1.95% less ownership
Funds ownership: 82.81% → 80.85% (-2%)
Holders
257
Holding in Top 10
6
Calls
$6.89M
Puts
$1.98M
Top Buyers
| 1 | +$18.4M | |
| 2 | +$17.4M | |
| 3 | +$16.2M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$11.7M |
| 5 |
JAM
JW Asset Management
Miami Beach,
Florida
|
+$10.5M |
Top Sellers
| 1 | -$44.2M | |
| 2 | -$18.5M | |
| 3 | -$16M | |
| 4 |
Prudential Financial
Newark,
New Jersey
|
-$12.6M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$10.7M |